Adiposity and risk of thyroid cancer: A systematic review and meta-analysis

Obesity Reviews

Volumn 16, Issue 12, 2015, Pages 1042-1054

  Schmid, D ^a   Ricci, C ^a   Behrens, G ^a   Leitzmann, M F ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Adiposity; Meta analysis; Thyroid cancer

Indexed keywords

ABDOMINAL FAT; ABDOMINAL OBESITY; ANAPLASTIC THYROID CANCER; BODY MASS; CANCER INCIDENCE; CANCER RISK; HIP CIRCUMFERENCE; HUMAN; OBESITY; REVIEW; SYSTEMATIC REVIEW; THYROID CANCER; THYROID CARCINOMA; THYROID FOLLICULAR CARCINOMA; UNDERWEIGHT; WAIST CIRCUMFERENCE; WAIST HIP RATIO; WEIGHT GAIN; AGE; CELL TRANSFORMATION; COMPLICATION; IMMUNOLOGY; META ANALYSIS; PATHOLOGY; PREVALENCE; RISK FACTOR; THYROID NEOPLASMS;

ADIPOSITY; AGE FACTORS; BODY MASS INDEX; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; OBESITY; PREVALENCE; RISK FACTORS; THYROID NEOPLASMS; WAIST-HIP RATIO;

EID: 84947866471     PISSN: 14677881     EISSN: 1467789X     Source Type: Journal    
DOI: 10.1111/obr.12321     Document Type: Review

References (107)

1. Siegel R, DeSantis C, Virgo K etal. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62: 220-241.
2. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006; 295: 2164-2167.
3. American Cancer Society. What are the key statistics about thyroid cancer? 2014. URL http://www.cancer.org/cancer/thyroidcancer/detailedguide/thyroid-cancer-key-statistics. (accessed January 29, 2015).
4. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J etal. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer 2013; 49: 1374-1403.
5. Kent WD, Hall SF, Isotalo PA, Houlden RL, George RL, Groome PA. Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ 2007; 177: 1357-1361.
6. Flegal KM. Epidemiologic aspects of overweight and obesity in the United States. Physiol Behav 2005; 86: 599-602.
7. World Health Organization (WHO). BMI classification. 2006. URL http://apps.who.int/bmi/index.jsp?introPage=intro_3.html (accessed March 27, 2013).
8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
9. Brindel P, Doyon F, Rachedi F etal. Anthropometric factors in differentiated thyroid cancer in French Polynesia: a case-control study. Cancer Causes Control 2009; 20: 581-590.
10. Bhaskaran K, Douglas I, Forbes H, dos Santos-Silva I, Leon DA, Smeeth L. Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults. Lancet 2014; 384: 755-765.
11. Guignard R, Truong T, Rougier Y, Baron-Dubourdieu D, Guenel P. Alcohol drinking, tobacco smoking, and anthropometric characteristics as risk factors for thyroid cancer: a countrywide case-control study in New Caledonia. Am J Epidemiol 2007; 166: 1140-1149.
12. Meinhold CL, Ron E, Schonfeld SJ etal. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study. Am J Epidemiol 2010; 171: 242-252.
13. Clero E, Leux C, Brindel P etal. Pooled analysis of two case-control studies in New Caledonia and French Polynesia of body mass index and differentiated thyroid cancer: the importance of body surface area. Thyroid 2010; 20: 1285-1293.
14. Tulinius H, Sigfusson N, Sigvaldason H, Bjarnadottir K, Tryggvadottir L. Risk factors for malignant diseases: a cohort study on a population of 22, 946 Icelanders. Cancer Epidemiol Biomarkers Prev 1997; 6: 863-873.
15. Song YM, Sung J, Ha M. Obesity and risk of cancer in postmenopausal Korean women. J Clin Oncol 2008; 26: 3395-3402.
16. Kabat GC, Kim MY, Thomson CA, Luo J, Wactawski-Wende J, Rohan TE. Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women. Cancer Causes Control 2012; 23: 421-430.
17. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
18. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
19. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
20. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol 2012; 175: 66-73.
21. Wells GA, Shea B, O'Connell D etal. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomized studies in meta-analyses. 2013. URL http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (accessed March 27, 2013).
22. Paoff K, Preston-Martin S, Mack WJ, Monroe K. A case-control study of maternal risk factors for thyroid cancer in young women (California, United States). Cancer Causes Control 1995; 6: 389-397.
23. Han JM, Kim TY, Jeon MJ etal. Obesity is a risk factor for thyroid cancer in a large, ultrasonographically screened population. Eur J Endocrinol 2013; 168: 879-886.
24. Mijovic T, How J, Pakdaman M etal. Body mass index in the evaluation of thyroid cancer risk. Thyroid 2009; 19: 467-472.
25. Harari A, Endo B, Nishimoto S, Ituarte PH, Yeh MW. Risk of advanced papillary thyroid cancer in obese patients. Arch Surg 2012; 147: 805-811.
26. Kim JY, Jung EJ, Park ST etal. Body size and thyroid nodules in healthy Korean population. J Korean Surg Soc 2012; 82: 13-17.
27. Kitahara CM, Gamborg M, Berrington de Gonzalez A, Sorensen TI, Baker JL. Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study. Cancer Res 2014; 74: 235-242.
28. Zivaljevic V, Slijepcevic N, Sipetic S etal. Risk factors for well-differentiated thyroid cancer in men. Tumori 2013; 99: 458-462.
29. Zivaljevic V, Tausanovic K, Sipetic S etal. A case-control study of papillary thyroid cancer in children and adolescents. Eur J Cancer Prev 2013; 22: 561-565.
30. Kalezic NK, Zivaljevic VR, Slijepcevic NA, Paunovic IR, Diklic AD, Sipetic SB. Risk factors for sporadic medullary thyroid carcinoma. Eur J Cancer Prev 2013; 22: 262-267.
31. Lee SM, Kwak KH. Risk factors and a predictive model for thyroid cancer in Korean women. Cancer Nurs 2010; 33: 310-319.
32. Balkan F, Onal ED, Usluogullari A etal. Is there any association between insulin resistance and thyroid cancer?: a case control study. Endocrine 2014; 45: 55-60.
33. Balkan F, Usluogullari CA, Ucler R, Baser H, Ersoy R, Cakir B. Does increased body mass index lead to elevated thyroid cancer risk? Endocrinol Metab Syndr 2014; 2: 1-4. doi: 10.4172/2161-1017.1000132.
34. Goodman MT, Kolonel LN, Wilkens LR. The association of body size, reproductive factors and thyroid cancer. Br J Cancer 1992; 66: 1180-1184.
35. Kim JY, Jung EJ, Jeong SH etal. The indices of body size and aggressiveness of papillary thyroid carcinoma. J Korean Surg Soc 2011; 80: 241-244.
36. McTiernan A, Weiss NS, Daling JR. Incidence of thyroid cancer in women in relation to known or suspected risk factors for breast cancer. Cancer Res 1987; 47: 292-295.
37. Tresallet C, Seman M, Tissier F etal. The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices. Surgery 2014; 156: 1145-1152. doi: 10.1016/j.surg.2014.04.020.
38. Boru C, Silecchia G, Pecchia A etal. Prevalence of cancer in Italian obese patients referred for bariatric surgery. Obes Surg 2005; 15: 1171-1176.
39. Paes JE, Hua K, Nagy R, Kloos RT, Jarjoura D, Ringel MD. The relationship between body mass index and thyroid cancer pathology features and outcomes: a clinicopathological cohort study. J Clin Endocrinol Metab 2010; 95: 4244-4250.
40. Kim HJ, Kim NK, Choi JH etal. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer. Clin Endocrinol (Oxf) 2013; 78: 134-140.
41. Dieringer P, Klass EM, Caine B, Smith-Gagen J. Associations between body mass and papillary thyroid cancer stage and tumor size: a population-based study. J Cancer Res Clin Oncol 2014; 141: 93-98. doi: 10.1007/s00432-014-1792-2.
42. Randi G, Ferraroni M, Talamini R etal. Glycemic index, glycemic load and thyroid cancer risk. Ann Oncol 2008; 19: 380-383.
43. Cash SW, Ma H, Horn-Ross PL etal. Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study. Cancer Epidemiol 2013; 37: 46-53.
44. Almquist M, Johansen D, Bjorge T etal. Metabolic factors and risk of thyroid cancer in the Metabolic syndrome and Cancer project (Me-Can). Cancer Causes Control 2011; 22: 743-751.
45. Xhaard C, Ren Y, Clero E etal. Differentiated thyroid carcinoma risk factors in French Polynesia. Asian Pac J Cancer Prev 2014; 15: 2675-2680.
46. Clavel-Chapelon F, Guillas G, Tondeur L, Kernaleguen C, Boutron-Ruault MC. Risk of differentiated thyroid cancer in relation to adult weight, height and body shape over life: the French E3N cohort. Int J Cancer 2010; 126: 2984-2990.
47. Samanic C, Gridley G, Chow WH, Lubin J, Hoover RN, Fraumeni JF Jr. Obesity and cancer risk among white and black United States veterans. Cancer Causes Control 2004; 15: 35-43.
48. Iribarren C, Haselkorn T, Tekawa IS, Friedman GD. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer 2001; 93: 745-750.
49. Wie GA, Cho YA, Kang HH etal. Red meat consumption is associated with an increased overall cancer risk: a prospective cohort study in Korea. Br J Nutr 2014; 112: 238-247.
50. Marcello MA, Sampaio AC, Geloneze B, Vasques AC, Assumpcao LV, Ward LS. Obesity and excess protein and carbohydrate consumption are risk factors for thyroid cancer. Nutr Cancer 2012; 64: 1190-1195.
51. Mack WJ, Preston-Martin S, Bernstein L, Qian D. Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 2002; 12: 395-401.
52. Preston-Martin S, Jin F, Duda MJ, Mack WJ. A case-control study of thyroid cancer in women under age 55 in Shanghai (People's Republic of China). Cancer Causes Control 1993; 4: 431-440.
53. Andreotti G, Hou L, Beane Freeman LE etal. Body mass index, agricultural pesticide use, and cancer incidence in the Agricultural Health Study cohort. Cancer Causes Control 2010; 21: 1759-1775.
54. Farfel A, Kark JD, Derazne E etal. Predictors for thyroid carcinoma in Israel: a national cohort of 1, 624, 310 adolescents followed for up to 40 years. Thyroid 2014; 24: 987-993.
55. Kitahara CM, Platz EA, Freeman LE etal. Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies. Cancer Epidemiol Biomarkers Prev 2011; 20: 464-472.
56. Kitahara CM, Platz EA, Park Y, Hollenbeck AR, Schatzkin A, Berrington de Gonzalez A. Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer 2012; 130: 1411-1419.
57. Leitzmann MF, Brenner A, Moore SC etal. Prospective study of body mass index, physical activity and thyroid cancer. Int J Cancer 2010; 126: 2947-2956.
58. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005; 23: 4742-4754.
59. Rapp K, Schroeder J, Klenk J etal. Obesity and incidence of cancer: a large cohort study of over 145, 000 adults in Austria. Br J Cancer 2005; 93: 1062-1067.
60. Rinaldi S, Lise M, Clavel-Chapelon F etal. Body size and risk of differentiated thyroid carcinomas: findings from the EPIC study. Int J Cancer 2012; 131: E1004-E1014.
61. Samanic C, Chow WH, Gridley G, Jarvholm B, Fraumeni JF Jr. Relation of body mass index to cancer risk in 362, 552 Swedish men. Cancer Causes Control 2006; 17: 901-909.
62. Dal Maso L, La Vecchia C, Franceschi S etal. A pooled analysis of thyroid cancer studies. V. Anthropometric factors. Cancer Causes Control 2000; 11: 137-144.
63. Suzuki T, Matsuo K, Hasegawa Y etal. Anthropometric factors at age 20 years and risk of thyroid cancer. Cancer Causes Control 2008; 19: 1233-1242.
64. Xu L, Port M, Landi S etal. Obesity and the risk of papillary thyroid cancer: a pooled analysis of three case-control studies. Thyroid 2014; 24: 966-974.
65. Engeland A, Tretli S, Akslen LA, Bjorge T. Body size and thyroid cancer in two million Norwegian men and women. Br J Cancer 2006; 95: 366-370.
66. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
67. Zhao ZG, Guo XG, Ba CX etal. Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res 2012; 40: 2041-2050.
68. Ma J, Huang M, Wang L, Ye W, Tong Y, Wang H. Obesity and risk of thyroid cancer: evidence from a meta-analysis of 21 observational studies. Med Sci Monit 2015; 21: 283-291.
69. Dobbins M, Decorby K, Choi BC. The association between obesity and cancer risk: a meta-analysis of observational studies from 1985 to 2011. ISRN Prev Med 2013; 1-16. doi: 10.5402/2013/680536.
70. Peterson E, De P, Nuttall R. BMI, diet and female reproductive factors as risks for thyroid cancer: a systematic review. PLoS ONE 2012; 7: e29177.
71. Pappa T, Alevizaki M. Obesity and thyroid cancer: a clinical update. Thyroid 2014; 24: 190-199.
72. Marcello MA, Cunha LL, Batista FA, Ward LS. Obesity and thyroid cancer. Endocr Relat Cancer 2014; 21: T255-T271.
73. Pazaitou-Panayiotou K, Polyzos SA, Mantzoros CS. Obesity and thyroid cancer: epidemiologic associations and underlying mechanisms. Obes Rev 2013; 14: 1006-1022.
74. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci 2014; 15: 6184-6223.
75. Rapp K, Schroeder J, Klenk J etal. Fasting blood glucose and cancer risk in a cohort of more than 140, 000 adults in Austria. Diabetologia 2006; 49: 945-952.
76. Gursoy A. Rising thyroid cancer incidence in the world might be related to insulin resistance. Med Hypotheses 2010; 74: 35-36.
77. Bae MJ, Kim SS, Kim WJ etal. High prevalence of papillary thyroid cancer in Korean women with insulin resistance. Head Neck 2014. doi: 10.1002/hed.23848.
78. Aschebrook-Kilfoy B, Sabra MM, Brenner A etal. Diabetes and thyroid cancer risk in the National Institutes of Health-AARP Diet and Health Study. Thyroid 2011; 21: 957-963.
79. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H. Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord 2009; 7: 375-380.
80. Tseng CH. Thyroid cancer risk is not increased in diabetic patients. PLoS ONE 2012; 7: e53096.
81. Akker M, Guldiken S, Sipahi T etal. Investigation of insulin resistance gene polymorphisms in patients with differentiated thyroid cancer. Mol Biol Rep 2014; 41: 3541-3547.
82. Park J, Scherer PE. Leptin and cancer: from cancer stem cells to metastasis. Endocr Relat Cancer 2011; 18: C25-C29.
83. Young O, Crotty T, O'Connell R, O'Sullivan J, Curran AJ. Levels of oxidative damage and lipid peroxidation in thyroid neoplasia. Head Neck 2010; 32: 750-756.
84. Metere A, Chiesa C, Di Cosimo C, Fierro G, Giacomelli L, Pietraforte D. A novel approach to study oxidative stress in thyroid diseases: a preliminary study. Eur Rev Med Pharmacol Sci 2012; 16: 646-652.
85. Pacifico F, Leonardi A. Role of NF-kappaB in thyroid cancer. Mol Cell Endocrinol 2010; 321: 29-35.
86. Kim WG, Park JW, Willingham MC, Cheng SY. Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model. Endocrinology 2013; 154: 2936-2947.
87. Roef G, Lapauw B, Goemaere S etal. Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men. Eur J Endocrinol 2012; 167: 719-726.
88. Alevizaki M, Saltiki K, Voidonikola P, Mantzou E, Papamichael C, Stamatelopoulos K. Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals. Eur J Endocrinol 2009; 161: 459-465.
89. Parameswaran R, Brooks S, Sadler GP. Molecular pathogenesis of follicular cell derived thyroid cancers. Int J Surg 2010; 8: 186-193.
90. Haymart MR, Glinberg SL, Liu J, Sippel RS, Jaume JC, Chen H. Higher serum TSH in thyroid cancer patients occurs independent of age and correlates with extrathyroidal extension. Clin Endocrinol (Oxf) 2009; 71: 434-439.
91. Klein S, Allison DB, Heymsfield SB etal. Waist circumference and cardiometabolic risk: a consensus statement from Shaping America's Health: Association for Weight Management and Obesity Prevention; NAASO, The Obesity Society; the American Society for Nutrition; and the American Diabetes Association. Am J Clin Nutr 2007; 85: 1197-1202.
92. Welborn TA, Dhaliwal SS, Bennett SA. Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust 2003; 179: 580-585.
93. Cameron AJ, Magliano DJ, Shaw JE etal. The influence of hip circumference on the relationship between abdominal obesity and mortality. Int J Epidemiol 2012; 41: 484-494.
94. Yusuf S, Hawken S, Ounpuu S etal. Obesity and the risk of myocardial infarction in 27, 000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640-1649.
95. Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceral fat, leptin, and insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 137-144.
96. Hoffstedt J, Arner E, Wahrenberg H etal. Regional impact of adipose tissue morphology on the metabolic profile in morbid obesity. Diabetologia 2010; 53: 2496-2503.
97. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med 2009; 6(Suppl. 1): 60-75.
98. Manole D, Schildknecht B, Gosnell B, Adams E, Derwahl M. Estrogen promotes growth of human thyroid tumor cells by different molecular mechanisms. J Clin Endocrinol Metab 2001; 86: 1072-1077.
99. Puhl RM, Heuer CA. The stigma of obesity: a review and update. Obesity (Silver Spring) 2009; 17: 941-964.
100. Ringback Weitoft G, Eliasson M, Rosen M. Underweight, overweight and obesity as risk factors for mortality and hospitalization. Scand J Public Health 2008; 36: 169-176.
101. Flegal KM, Graubard BI, Williamson DF, Gail MH. Cause-specific excess deaths associated with underweight, overweight, and obesity. JAMA 2007; 298: 2028-2037.
102. Liska J, Altanerova V, Galbavy S, Stvrtina S, Brtko J. Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Regul 2005; 39: 73-83.
103. Carling T, Udelsman R. Thyroid cancer. Annu Rev Med 2014; 65: 125-137.
104. Cheng SP, Yin PH, Hsu YC etal. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways. Oncol Rep 2011; 26: 1265-1271.
105. Cheng SP, Yin PH, Chang YC, Lee CH, Huang SY, Chi CW. Differential roles of leptin in regulating cell migration in thyroid cancer cells. Oncol Rep 2010; 23: 1721-1727.
106. Tehard B, van Liere MJ, Com Nougue C, Clavel-Chapelon F. Anthropometric measurements and body silhouette of women: validity and perception. J Am Diet Assoc 2002; 102: 1779-1784.
107. Zevallos JP, Hartman CM, Kramer JR, Sturgis EM, Chiao EY. Increased thyroid cancer incidence corresponds to increased use of thyroid ultrasound and fine-needle aspiration: a study of the Veterans Affairs health care system. Cancer 2015; 121: 741-746.